We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+5.93%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$28.6B
AUM Growth
+$1.5B
Cap. Flow
+$262M
Cap. Flow %
0.92%
Top 10 Hldgs %
43.01%
Holding
291
New
10
Increased
102
Reduced
100
Closed
10

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$67.8M
2
MSFT icon
Microsoft
MSFT
+$65M
3
AAPL icon
Apple
AAPL
+$45M
4
AMZN icon
Amazon
AMZN
+$42.8M
5
PM icon
Philip Morris
PM
+$40.2M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$56.2M
2
META icon
Meta Platforms (Facebook)
META
+$38.9M
3
AXP icon
American Express
AXP
+$32.9M
4
MS icon
Morgan Stanley
MS
+$32.6M
5
PG icon
Procter & Gamble
PG
+$31.9M

Sector Composition

Rank Sector Weight
1 Technology 23.05%
2 Consumer Staples 18.27%
3 Financials 17.61%
4 Energy 12.56%
5 Healthcare 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLB icon
126
SLB Ltd
SLB
$74.1B
$2.97M 0.01%
60,423
-143
-0.2% -$7.59K
OVV icon
127
Ovintiv
OVV
$16B
$2.95M 0.01%
81,733
– –
RACE icon
128
Ferrari
RACE
$71.5B
$2.95M 0.01%
10,870
+2,300
+27% +$587K
RETA
129
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$2.76M 0.01%
30,329
– –
BTI icon
130
British American Tobacco
BTI
$128B
$2.71M 0.01%
77,250
– –
ROK icon
131
Rockwell Automation
ROK
$50.1B
$2.54M 0.01%
8,648
+4,819
+126% +$1.37M
EMR icon
132
Emerson Electric
EMR
$91B
$2.46M 0.01%
28,282
+120
+0.4% +$10.5K
RL icon
133
Ralph Lauren
RL
$22.7B
$2.44M 0.01%
20,900
– –
FCX icon
134
Freeport-McMoran
FCX
$99.8B
$2.42M 0.01%
59,069
+24,359
+70% +$1.01M
IFF icon
135
International Flavors & Fragrances
IFF
$22.5B
$2.36M 0.01%
25,638
+5,669
+28% +$564K
FOXA icon
136
Fox Class A
FOXA
$24.6B
$2.33M 0.01%
68,391
-267
-0.4% -$9.02K
NSC icon
137
Norfolk Southern
NSC
$76.8B
$2.26M 0.01%
10,644
– –
IBM icon
138
IBM
IBM
$222B
$2.23M 0.01%
17,003
-1,046
-6% -$140K
CCI icon
139
Crown Castle
CCI
$32.3B
$2.22M 0.01%
16,619
-1,038
-6% -$143K
REGN icon
140
Regeneron Pharmaceuticals
REGN
$79.1B
$2.2M 0.01%
2,675
+25
+0.9% +$18.9K
DHR icon
141
Danaher
DHR
$140B
$2.14M 0.01%
9,589
+187
+2% +$42.5K
TMO icon
142
Thermo Fisher Scientific
TMO
$214B
$2.12M 0.01%
3,681
-37
-1% -$20.9K
PAYX icon
143
Paychex
PAYX
$42.1B
$2.11M 0.01%
18,429
-92
-0.5% -$10.5K
CSX icon
144
CSX Corp
CSX
$94.7B
$2.07M 0.01%
69,000
-1,404
-2% -$43.2K
BIIB icon
145
Biogen
BIIB
$30.5B
$2.06M 0.01%
7,413
– –
TSM icon
146
TSMC
TSM
$2.15T
$2.06M 0.01%
22,101
+11,519
+109% +$1.03M
ICLR icon
147
Icon
ICLR
$12.6B
$2.02M 0.01%
9,440
+5,200
+123% +$1.16M
CSCO icon
148
Cisco
CSCO
$479B
$1.89M 0.01%
36,235
-10,650
-23% -$520K
UPS icon
149
United Parcel Service
UPS
$91.5B
$1.81M 0.01%
9,306
-546
-6% -$100K
MRSH
150
Marsh
MRSH
$91.4B
$1.8M 0.01%
10,815
+1
+0% +$167
4 5
6
7 8

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Fayez Sarofim & Co's Q1 2023 Portfolio in Review

As of Q1 2023, Fayez Sarofim & Co held 291 positions worth $28.6B, up 5.6% from $27.1B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Fayez Sarofim & Co's Q1 2023 filing shows 10 new, 102 increased, 100 reduced and 10 closed positions. Its largest new stake was MSCI: 9,600 shares worth $5.37M. The largest sale was Johnson & Johnson, an estimated $56.2M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Consumer Staples and Financials.

  • Fayez Sarofim & Co's largest Q1 2023 buy was MSCI: 9,600 shares worth $5.37M.
  • Fayez Sarofim & Co added most to AstraZeneca in Q1 2023, an estimated $67.8M increase.
  • Fayez Sarofim & Co's biggest Q1 2023 reduction was Johnson & Johnson, cutting an estimated $56.2M.
  • Fayez Sarofim & Co fully exited Cohen & Steers in Q1 2023, selling an estimated $3.23M.
  • Fayez Sarofim & Co's ten largest holdings make up 43% of its $28.6B portfolio in Q1 2023.
  • Fayez Sarofim & Co opened 10 new positions and closed 10 in Q1 2023.
  • Fayez Sarofim & Co's portfolio value rose 5.6% quarter-over-quarter to $28.6B.

Based on Fayez Sarofim & Co's 13F filing for Q1 2023, filed 11 May 2023.